Mechanism of Virulence Attenuation of Glycosaminoglycan-Binding Variants of Japanese Encephalitis Virus and Murray Valley Encephalitis Virus
Open Access
- 15 May 2002
- journal article
- research article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 76 (10) , 4901-4911
- https://doi.org/10.1128/jvi.76.10.4901-4911.2002
Abstract
The in vivo mechanism for virulence attenuation of laboratory-derived variants of two flaviviruses in the Japanese encephalitis virus (JEV) serocomplex is described. Host cell adaptation of JEV and Murray Valley encephalitis virus (MVE) by serial passage in adenocarcinoma cells selected for variants characterized by (i) a small plaque phenotype, (ii) increased affinity to heparin-Sepharose, (iii) enhanced susceptibility to inhibition of infectivity by heparin, and (iv) loss of neuroinvasiveness in a mouse model for flaviviral encephalitis. We previously suggested that virulence attenuation of the host cell-adapted variants of MVE is a consequence of their increased dependence on cell surface glycosaminoglycans (GAGs) for attachment and entry (E. Lee and M. Lobigs, J. Virol. 74:8867-8875, 2000). In support of this proposition, we find that GAG-binding variants of JEV and MVE were rapidly removed from the bloodstream and failed to spread from extraneural sites of replication into the brain. Thus, the enhanced affinity of the attenuated variants for GAGs ubiquitously present on cells and extracellular matrices most likely prevented viremia of sufficient magnitude and/or duration required for virus entry into the brain parenchyma. This mechanism may also account, in part, for the attenuation of the JEV SA14-14-2 vaccine, given the sensitivity of the virus to heparin inhibition. A pronounced loss of the capacity of the GAG-binding variants to produce disease was also noted in mice defective in the alpha/beta interferon response, a mouse strain shown here to be highly susceptible to infection with JEV serocomplex flaviviruses. Despite the close genetic relatedness of JEV and MVE, the variants selected for the two viruses were altered at different residues in the envelope (E) protein, viz., Glu306 and Asp390 for JEV and MVE, respectively. In both cases the substitutions gave the protein an increased net positive charge. The close spatial proximity of amino acids 306 and 390 in the predicted E protein structure strongly suggests that the two residues define a receptor-binding domain involved in virus attachment to sulfated proteoglycans.Keywords
This publication has 35 references indexed in Scilit:
- Adaptation of Tick-Borne Encephalitis Virus to BHK-21 Cells Results in the Formation of Multiple Heparan Sulfate Binding Sites in the Envelope Protein and Attenuation In VivoJournal of Virology, 2001
- Mutations in the E2 Glycoprotein of Venezuelan Equine Encephalitis Virus Confer Heparan Sulfate Interaction, Low Morbidity, and Rapid Clearance from Blood of MiceVirology, 2000
- Functions of Cell Surface Heparan Sulfate ProteoglycansAnnual Review of Biochemistry, 1999
- Characterization of a Highly Attenuated Japanese Encephalitis Virus Generated from Molecularly Cloned cDNAThe Journal of Infectious Diseases, 1995
- The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolutionNature, 1995
- Molecular basis of attenuation of neurovirulence of wild-type Japanese encephalitis virus strain SA14Journal of General Virology, 1995
- Functional Role of Type I and Type II Interferons in Antiviral DefenseScience, 1994
- GENETIC DIFFERENTIATION OF MURRAY VALLEY ENCEPHALITIS VIRUS IN AUSTRALIA AND PAPUA NEW GUINEAImmunology & Cell Biology, 1986
- The Flaviviruses (Group B Arboviruses): a Cross-neutralization StudyJournal of General Virology, 1974
- MURRAY VALLEY ENCEPHALITIS INFECTION IN THE LABORATORY MOUSEImmunology & Cell Biology, 1952